TY - JOUR
T1 - Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson's disease
AU - Nishioka, Kenya
AU - Hashizume, Yoshio
AU - Takanashi, Masashi
AU - Daida, Kensuke
AU - Li, Yuanzhe
AU - Yoshino, Hiroyo
AU - Tambasco, Nicola
AU - Prontera, Paolo
AU - Hattori, Yuko
AU - Ueda, Akihiro
AU - Watanabe, Hirohisa
AU - Hattori, Nobutaka
N1 - Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/12
Y1 - 2020/12
N2 - The present report documents a patient harboring an alpha-synuclein p.A53T variant from a family presenting with autosomal dominant inheritance, including four patients clinically diagnosed with Parkinson's disease (PD) and two with dementia. The alpha-synuclein p.A53T variant is linked to young- or middle-aged onset parkinsonism and cognitive decline. Our patient had a different haplotype from that of a patient with a p.A53T variant from an Italian family. The proband presented at 42 years of age with progressive parkinsonism and good response to levodopa in the early stages of the disease. At 46 years of age, he developed delusions and cognitive decline. Brain magnetic resonance imaging showed bilateral atrophic changes in the hippocampus and temporal lobes. He died of pneumonia at the age of 52 years. Neuropathological examination revealed severe neuronal loss in the substantia nigra, locus coeruleus, and dorsal nucleus of the vagus nerve, as well as widespread Lewy pathology including Lewy bodies and neurites, corresponding to Braak stage 6, and diffuse neocortical-type PD. There was mild appearance of tau pathology and glial cytoplasmic inclusion, in the absence of TDP-43 pathology. Alpha-synuclein p.A53T characteristically cause the Lewy body pathology and the symptoms, that resembled those of the reported patients with p.A53T.
AB - The present report documents a patient harboring an alpha-synuclein p.A53T variant from a family presenting with autosomal dominant inheritance, including four patients clinically diagnosed with Parkinson's disease (PD) and two with dementia. The alpha-synuclein p.A53T variant is linked to young- or middle-aged onset parkinsonism and cognitive decline. Our patient had a different haplotype from that of a patient with a p.A53T variant from an Italian family. The proband presented at 42 years of age with progressive parkinsonism and good response to levodopa in the early stages of the disease. At 46 years of age, he developed delusions and cognitive decline. Brain magnetic resonance imaging showed bilateral atrophic changes in the hippocampus and temporal lobes. He died of pneumonia at the age of 52 years. Neuropathological examination revealed severe neuronal loss in the substantia nigra, locus coeruleus, and dorsal nucleus of the vagus nerve, as well as widespread Lewy pathology including Lewy bodies and neurites, corresponding to Braak stage 6, and diffuse neocortical-type PD. There was mild appearance of tau pathology and glial cytoplasmic inclusion, in the absence of TDP-43 pathology. Alpha-synuclein p.A53T characteristically cause the Lewy body pathology and the symptoms, that resembled those of the reported patients with p.A53T.
UR - http://www.scopus.com/inward/record.url?scp=85096223811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096223811&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2020.11.001
DO - 10.1016/j.parkreldis.2020.11.001
M3 - Article
C2 - 33171430
AN - SCOPUS:85096223811
SN - 1353-8020
VL - 81
SP - 183
EP - 187
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
ER -